Call to EU Commission and donors for concrete actions to result in access for all

As the global pledging conference will be hosted by the EU Commission today May 4th, Global Health Advocates endorsed, with other health CSOs, a public statement coordinated by the European Alliance for Responsible R&D and Affordable Medicines, that calls for a strong accountable global coordination mechanism to ensure equitable access to safe, quality, effective and affordable diagnostics and therapeutics against Covid-19.

We invite the EU and all the other donors and partners to the pledging conference to set up a transparent and inclusive governance structure to decide on priorities, monitor progress, evaluate and report on the results of the pledges and further investments.

« We invite the EU and all the other donors and partners to the pledging conference to set up a transparent and inclusive governance structure to decide on priorities, monitor progress, evaluate and report on the results of the pledges and further investments. A robust accountability mechanism should also be put in place to ensure that commitments are translated into actions. The meaningful involvement of civil society organisations should be ensured in all governance structures.

The pledging conference can provide the financial means to overcome some barriers. A plan detailing how each of these barriers will be addressed is needed. This plan should comprise a shared definition of what global equitable access, affordability and availability mean and detailed conditions under which partners are expected to contribute to fulfilling these ambitions in return for funding. As the pledging conference aims to raise funding from across the world to address the needs of all, this information should be publicly available. »

Read full statement here : https://medicinesalliance.eu/wp-content/uploads/2020/05/Statement-pledging-conference-4th-May.pdf